Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Constitutive NF-kB Activation Is Amplified by VSV in Aggressive PC3 Prostate Cancer Cells That Resist Viral Oncolysis.

Viruses·2026
Same author

QuickDraw: detecting HIV in whole blood using an integrated paper-based consumable that enables direct amplification of purified RNA from paper.

Lab on a chip·2026
Same author

LAIV Mutations Selectively Alter Influenza Viral RNA Polymerase Function, Favoring Transcription over Genome Synthesis.

Viruses·2025
Same author

Constitutive NF-κB Activation is Amplified by VSV in Aggressive PC3 Prostate Cancer Cells that Resist Viral Oncolysis.

bioRxiv : the preprint server for biology·2025
Same author

Antibody Responses to SARS-CoV-2 and Common HCoVs in Hemodialysis Patients and Transplant Recipients: Data from the Dominican Republic.

Vaccines·2025
Same author

Acquisition of quaternary trimer interaction as a key step in the lineage maturation of a broad and potent HIV-1 neutralizing antibody.

Structure (London, England : 1993)·2025

Related Experiment Video

Updated: May 27, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Advances in HIV microbicide development.

Joanna S Olsen1, David Easterhoff, Stephen Dewhurst

  • 1Department of Microbiology & Immunology, University of Rochester, Rochester, NY 14627, USA.

Future Medicinal Chemistry
|November 22, 2011
PubMed
Summary
This summary is machine-generated.

Developing effective microbicides is crucial for controlling the global human immunodeficiency virus (HIV) pandemic. Understanding mucosal immunity is key to creating topical drugs that safely block HIV transmission.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Experiment Videos

Last Updated: May 27, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • The global spread of human immunodeficiency virus (HIV) necessitates novel prevention strategies.
  • Microbicides, topical drugs applied to mucosal surfaces, represent a promising approach to block HIV transmission.
  • A comprehensive understanding of the mucosal environment and its role in HIV infection is essential for microbicide development.

Purpose of the Study:

  • To review current research on the development of HIV microbicides.
  • To highlight the importance of understanding mucosal immunity in designing effective microbicides.
  • To identify key viral infection events that can be targeted by microbicides.

Main Methods:

  • This review synthesizes existing research on HIV microbicide development.
  • It examines the role of cervicovaginal and rectal mucosa in innate defense against HIV.
  • The review discusses critical events in viral infection relevant to microbicide targeting.

Main Results:

  • Microbicide development requires a deep understanding of mucosal defense mechanisms.
  • Microbicides must not compromise the natural protective functions of the cervicovaginal and rectal mucosa.
  • Targeting key events in the HIV viral lifecycle is crucial for microbicide efficacy.

Conclusions:

  • Further research into mucosal immunity and HIV transmission is vital for advancing microbicide development.
  • Safe and effective microbicides hold significant potential for global HIV prevention efforts.
  • Integrating knowledge of viral dynamics and mucosal defense is key to successful microbicide design.